Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Tongli Pharmaceuticals (USA), Inc. | v317170_10k.htm |
| EX-21.1 - EXHIBIT 21.1 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex21-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex31-2.htm |
| EX-10.2 - EXHIBIT 10.2 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex10-2.htm |
| EX-10.3 - EXHIBIT 10.3 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex10-3.htm |
| EX-31.1 - EXHIBIT 31.1 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Tongli Pharmaceuticals (USA), Inc. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - Tongli Pharmaceuticals (USA), Inc. | v317170_ex32-1.htm |
EXHIBIT 32.2
CERTIFICATION
Pursuant to 18 U.S.C. 1350
(Section 302 of the Sarbanes-Oxley Act of 2002)
In connection with the Annual Report on Form 10-K of Tongli Pharmaceuticals (USA), Inc. (the “Company”) for the year ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Li Li, principal financial officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: July 16, 2012
| By: | /s/ Li Li | |
| Name: | Li Li | |
| Title: |
Chief Financial Officer (principal financial and accounting officer) |
This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.